To All,
GlaxoSmithKline PLC and its development partner Genmab came one step closer Friday to gaining approval on their cancer treatment Arzerra after an advisory panel recommended the Food and Drug Administration approve the therapy.
Just read this off MSN. Passing it on.
Damon